| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $489.4M | +30.5% |
| Cost of Revenue | $179.3M | +56.6% |
| Gross Profit | $310.1M | +19.1% |
| R&D Expense | $156.8M | +183.6% |
| SG&A Expense | $144.0M | +140.5% |
| Operating Income | -$319.5M | -947.2% |
| Pre-tax Income | -$304.8M | -1007.7% |
| Income Tax | $1.9M | +32.6% |
| Net Income | -$216.2M | -647.3% |
| EPS (Basic) | -$1.23 | — |
| EPS (Diluted) | -$1.25 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $544.2M | +364.8% |
| Accounts Receivable | $129.0M | +20.2% |
| Current Assets | $737.4M | +157.6% |
| Total Assets | $823.2M | +127.7% |
| Current Liabilities | $312.2M | +34.3% |
| Total Liabilities | $332.3M | +30.3% |
| Stockholders' Equity | $386.2M | +262.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $61.2M | +187.6% |
| Capital Expenditures | $2.6M | +1.1% |
| Investing Cash Flow | -$10.2M | -112.0% |
| Financing Cash Flow | $376.5M | +9890.7% |
| Free Cash Flow | $58.5M | +213.4% |